Intelligence · Clinical Pipeline
Denali Therapeutics Pipeline
All ClinicalTrials.gov programs at Denali Therapeutics — phase, modality, and trial IDs.
- Programs
- 13
Quick answer
Denali Therapeutics has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants with Early Alzheimer’s Disease
Denali Therapeutics
Early Alzheimer's Disease
1 trial -
BIIB122 (DNL151)
Denali Therapeutics
Healthy Volunteers
1 trial -
DNL151
Denali Therapeutics
Healthy Volunteers
1 trial -
DNL201
Denali Therapeutics
Parkinson Disease
1 trial -
DNL201
Denali Therapeutics
Healthy Volunteers
1 trial -
DNL343
Denali Therapeutics
Healthy Volunteers
2 trials -
DNL628
Denali Therapeutics
Alzheimer Disease, Early Onset
1 trial -
DNL747
Denali Therapeutics
Alzheimer Disease
1 trial -
DNL747
Denali Therapeutics
Amyotrophic Lateral Sclerosis
1 trial -
DNL919
Denali Therapeutics
Healthy Participant
1 trial -
DNL952
Denali Therapeutics
Late-onset Pompe Disease
1 trial -
[14C] BIIB122 ([14C] DNL151)
Denali Therapeutics
Healthy Volunteers
1 trial -
[14C]-DNL343
Denali Therapeutics
Healthy Volunteers
1 trial
Frequently asked questions
How many pipeline programs does Denali Therapeutics have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs